These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 7848103)

  • 1. [Proliferative activity of basal cell and metatypical cell carcinoma of the skin].
    Kazantseva IA; Khlebnikova AN; Babaev VR; Fager G
    Arkh Patol; 1994; 56(4):35-8. PubMed ID: 7848103
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunohistochemical study of primary and recurrent basal cell and metatypical carcinomas of the skin.
    Kazantseva IA; Khlebnikova AN; Babaev VR
    Am J Dermatopathol; 1996 Feb; 18(1):35-42. PubMed ID: 8721589
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Metatypical basal-cell carcinoma (MTC) or basosquamos carcinoma (BSC): surgical therapy].
    Tarallo M; Cigna E; Fino P; Sorvillo V; Scuderi N
    Ann Ital Chir; 2011; 82(5):389-94. PubMed ID: 21988047
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The use of antidesmoglein stains in Mohs micrographic surgery. A potential aid for the differentiation of basal cell carcinoma from horizontal sections of the hair follicle and folliculocentric basaloid proliferation.
    Krunic AL; Garrod DR; Viehman GE; Madani S; Buchanan MD; Clark RE
    Dermatol Surg; 1997 Jun; 23(6):463-8. PubMed ID: 9217798
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Immunomorphological features of cutaneous basal-cell carcinoma].
    Chuprov IN
    Vopr Onkol; 2008; 54(6):715-9. PubMed ID: 19241845
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The detection of basal cell determinants in human basal cell carcinomas using two different monoclonal antibodies.
    Habets JM; Tank B; Vuzevski VD; van Reede EC; Stolz E; van Joost T
    Acta Derm Venereol; 1987; 67(5):391-8. PubMed ID: 2448989
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Squamous cell carcinoma of the skin: dual differentiations to rare basosquamous and spindle cell variants.
    Mitsuhashi T; Itoh T; Shimizu Y; Ban S; Ogawa F; Hirose T; Shimizu M
    J Cutan Pathol; 2006 Mar; 33(3):246-52. PubMed ID: 16466514
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Decreased expression of thymidine phosphorylase/platelet-derived endothelial cell growth factor in basal cell carcinomas.
    Stoebner PE; Le Gallic L; Berthe ML; Boulle N; Lallemant B; Marque M; Gaspard C; Delfour C; Lavabre-Bertrand T; Martinez J; Meunier L
    Exp Dermatol; 2008 Nov; 17(11):908-15. PubMed ID: 18341568
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased expression of COX-2 in recurrent basal cell carcinoma of the skin: a pilot study.
    Karahan N; Baspinar S; Bozkurt KK; Caloglu E; Ciris IM; Kapucuoglu N
    Indian J Pathol Microbiol; 2011; 54(3):526-31. PubMed ID: 21934214
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Basal cell carcinoma treated with Mohs surgery in Australia I. Experience over 10 years.
    Leibovitch I; Huilgol SC; Selva D; Richards S; Paver R
    J Am Acad Dermatol; 2005 Sep; 53(3):445-51. PubMed ID: 16112351
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oral carcinoma in situ. Its progression to squamous, basosquamous, and basal-cell carcinoma.
    Fresko D; Lazarus SS
    Arch Pathol Lab Med; 1981 Jan; 105(1):15-9. PubMed ID: 6893909
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ki67 as a biologic marker of basal cell carcinoma: a retrospective study.
    Kramer E; Herman O; Frand J; Leibou L; Schreiber L; Vaknine H
    Isr Med Assoc J; 2014 Apr; 16(4):229-32. PubMed ID: 24834759
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Superficial radiotherapy for patients with basal cell carcinoma: recurrence rates, histologic subtypes, and expression of p53 and Bcl-2.
    Zagrodnik B; Kempf W; Seifert B; Müller B; Burg G; Urosevic M; Dummer R
    Cancer; 2003 Dec; 98(12):2708-14. PubMed ID: 14669293
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Merkel cell-poor trichoblastoma with basal cell carcinoma-like foci.
    Misago N; Satoh T; Miura Y; Nagase K; Narisawa Y
    Am J Dermatopathol; 2007 Jun; 29(3):249-55. PubMed ID: 17519622
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Desmoplastic trichoepithelioma: a clinicopathological study, including a comparison with morpheiform basal cell carcinoma].
    Mitcov M; Scrivener Y; Cribier B
    Ann Dermatol Venereol; 2009; 136(6-7):501-7. PubMed ID: 19560610
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Basal cell carcinoma with mixed histology: a possible pathogenesis for recurrent skin cancer.
    Cohen PR; Schulze KE; Nelson BR
    Dermatol Surg; 2006 Apr; 32(4):542-51. PubMed ID: 16681663
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Differential diagnosis of basalioma and metatypical skin cancer].
    Kazantseva IA; Bogatyreva II; Vavilov AM; Parshikova SM
    Arkh Patol; 1983; 45(6):35-9. PubMed ID: 6625927
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Patients with both basal and squamous cell carcinomas are at a lower risk of further basal cell carcinomas than patients with only a basal cell carcinoma.
    Ramachandran S; Rajaratnam R; Smith AG; Lear JT; Strange RC
    J Am Acad Dermatol; 2009 Aug; 61(2):247-51. PubMed ID: 19481292
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative morphometric analysis of primary versus recurrent basal cell carcinoma and of histological subtypes. Significance of morphometry of the nuclei.
    Bierhoff E; Appel K; Appel T; Buettner R; Wardelmann E
    Anticancer Res; 2003; 23(3B):2697-700. PubMed ID: 12894560
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sarcomatoid basal cell carcinoma--predilection for osteosarcomatous differentiation: a series of 11 cases.
    Mc Menamin ME; Goh SG; Poblet E; Gostelow BE; Robson A; Calonje E
    Am J Surg Pathol; 2006 Oct; 30(10):1299-308. PubMed ID: 17001162
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.